AMNEAL PHARMACEUTICALS, INC. - DEF 14A

Company

Amneal Pharmaceuticals, Inc.

Filed

March 25, 2022

Period of Report

May 9, 2022

Accession Number

0001308179-22-000119

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →